Resultados de la búsqueda 521-530 of 10857 for polycystic ovary syndrome
All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...
Autosomal Dominant Polycystic Kidney Disease: Early intervention and lifestyle crucial March 24, 2025, 06:23 p.m. CDT; Science Saturday: Confronting ...
Science Saturday: Confronting polycystic kidney disease, a silent killer Aug. 12, 2023, 11:00 a.m. CDT. Productos y servicios. Boletín informativo: Mayo ...
Study of Breast Cancer Risk Assessment in Female Patients with Benign Breast Disease. Rochester, Minn., Jacksonville, Fla. The purpose of this study is to to ...
The purpose of phase 2a is to establish proof-of-concept (POC) for AG-946 in participants with lower-risk myelodysplastic syndromes (LR-MDS) and to evaluate ...
A Study to Assess Long-term Symptom Improvement and Recurrence after Operative Management of Popliteal Artery Entrapment Syndrome (PAES). Rochester, Minn ...
... disease with complete and long-term clinical follow-up to identify those who developed breast cancer (cases) and those who did not (controls); the ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?